These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37964294)

  • 21. Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia.
    Kjeldsen AD; Møller TR; Brusgaard K; Vase P; Andersen PE
    J Intern Med; 2005 Oct; 258(4):349-55. PubMed ID: 16164574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - Study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial.
    Andorfer KEC; Seebauer CT; Koller M; Zeman F; Berneburg M; Fischer R; Vielsmeier V; Bohr C; Kühnel TS
    Clin Hemorheol Microcirc; 2022; 80(3):307-315. PubMed ID: 34864649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients.
    Kjeldsen AD; Vase P; Green A
    J Intern Med; 1999 Jan; 245(1):31-9. PubMed ID: 10095814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT).
    Lee JM; Wu V; Faughnan ME; Lasso A; Figol A; Kilty SJ
    J Otolaryngol Head Neck Surg; 2019 Oct; 48(1):48. PubMed ID: 31615556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT).
    Zarrabeitia R; Fariñas-Álvarez C; Santibáñez M; Señaris B; Fontalba A; Botella LM; Parra JA
    Health Qual Life Outcomes; 2017 Jan; 15(1):19. PubMed ID: 28114930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia.
    Yin LX; Reh DD; Hoag JB; Mitchell SE; Mathai SC; Robinson GM; Merlo CA
    Laryngoscope; 2016 May; 126(5):1029-32. PubMed ID: 26393959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia.
    Al-Samkari H; Albitar HA; Olitsky SE; Clancy MS; Iyer VN
    Haemophilia; 2020 Nov; 26(6):1038-1045. PubMed ID: 32432841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification of endonasal HHT lesions using digital microscopy.
    Haubner F; Schneider A; Schinke H; Bertlich M; Weiss BG; Canis M; Kashani F
    Orphanet J Rare Dis; 2021 Apr; 16(1):182. PubMed ID: 33865423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of epistaxis in hereditary haemorrhagic telangiectasia (HHT) patients using pulsed dye laser and the effect of withholding treatment during the COVID pandemic.
    Jiang Y; Dennis SC; Brewin MP
    Lasers Med Sci; 2022 Oct; 37(8):3147-3153. PubMed ID: 35635649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary Haemorrhagic Telangiectasia (HHT) Marked by ACVRL1C1120T Variant Displays Hypopigmented Naevi and Frequent Bleeding Episodes if CYP2C9 Co-Mutated: Clinical Notes & Rationale of Patient Registry.
    Minarik L; Vargova K; Dusilkova N; Kulvait V; Jonasova A; Kodet O; Stopka T
    Folia Biol (Praha); 2020; 66(1):1-6. PubMed ID: 32512653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and Validation of the Nasal Outcome Score for Epistaxis in Hereditary Hemorrhagic Telangiectasia (NOSE HHT).
    Peterson AM; Kallogjeri D; Spitznagel E; Chakinala MM; Schneider JS; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):999-1005. PubMed ID: 33022056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
    Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
    Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hereditary hemorrhagic telangiectasia: symptoms and diagnostic latency].
    Droege F; Kuerten CHL; Kaiser C; Dingemann J; Kaster F; Dahlfrancis PM; Lueb C; Zioga E; Thangavelu K; Lang S; Geisthoff U
    Laryngorhinootologie; 2021 Jun; 100(6):443-452. PubMed ID: 33761571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
    Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Ramirez JR; Morales-Angulo C; Zarrabeitia R; Perez-Molino A; Bernabéu C; Botella LM
    Thromb Haemost; 2007 Feb; 97(2):254-62. PubMed ID: 17264955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?
    Dupuis-Girod S; Shovlin CL; Kjeldsen AD; Mager HJ; Sabba C; Droege F; Fargeton AE; Fialla AD; Gandolfi S; Hermann R; Lenato GM; Manfredi G; Post MC; Rennie C; Suppressa P; Sure U; ; Buscarini E
    Eur J Med Genet; 2022 Oct; 65(10):104575. PubMed ID: 35940549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical application of timolol decreases the severity and frequency of epistaxis in patients who have previously undergone nasal dermoplasty for hereditary hemorrhagic telangiectasia.
    Ichimura K; Kikuchi H; Imayoshi S; Dias MS
    Auris Nasus Larynx; 2016 Aug; 43(4):429-32. PubMed ID: 26739947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrin glue in initial treatment of epistaxis in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease).
    Vaiman M; Martinovich U; Eviatar E; Kessler A; Segal S
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):359-63. PubMed ID: 15166924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life.
    Baysal M; Ümit EG; Kırkızlar HO; Özdöver AC; Demir AM
    Turk J Haematol; 2019 Feb; 36(1):43-47. PubMed ID: 29880465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychosocial quality of life in hereditary haemorrhagic telangiectasia patients.
    Loaëc M; Morinière S; Hitier M; Ferrant O; Plauchu H; Babin E
    Rhinology; 2011 Jun; 49(2):164-7. PubMed ID: 21743870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia.
    Thompson KP; Sykes J; Chandakkar P; Marambaud P; Vozoris NT; Marchuk DA; Faughnan ME
    Orphanet J Rare Dis; 2022 Nov; 17(1):405. PubMed ID: 36344987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.